project id: TCGA-OV; case submitter id: TCGA-13-0723; selected normal wgs: true; selected normal wxs: true; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 8.4; spectrophotometer method: UV Spec; age at index: 63; days to birth: -23094; days to death: 1204; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1939; year of death: 2005; age at diagnosis: 23094; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1204.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2002; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 148.0; composition: Not Reported; intermediate dimension: 1.0; longest dimension: 1.3; preservation method: Unknown; shortest dimension: 0.3; sample id: bc90faa3-383c-4333-b774-580026c7ebd6; sample submitter id: TCGA-13-0723-01A; portion id: 8c9b89f6-7c25-466b-9862-06421983ccf5; portion submitter id: TCGA-13-0723-01A-02; percent lymphocyte infiltration: 70.0; percent neutrophil infiltration: 30.0; percent stromal cells: 2.0; percent tumor nuclei: 80.0;